FDA Drug Recalls

Recalls / Class III

Class IIID-1513-2020

Product

Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablet packets, Manufactured for: Convenience Valet Glendale Heights, IL 60139,

Affected lot / code info
Lot #: K-8909, AK8909, Exp. Date 12/2020; AK9507, Exp. Date 03/2021; AK9072, Exp. Date 04/2021; AK9102, AK9601, AK9679, Exp. Date 05/2021; AK9145, K9145, Exp. Date 06/2021; AK9743, AK9830, Exp. Date 07/2021; AK9276, Exp. Date 09/2021; AK9391, A9392, Exp. Date 12/2021; AK9505, Exp. Date 02/2022; AK9508, AK9509 Exp. Date 04/2022

Why it was recalled

Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Recalling firm

Firm
Ultra Seal Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
521 Main St, N/A, New Paltz, New York 12561-1609

Distribution

Quantity
701,735 packets
Distribution pattern
Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.

Timeline

Recall initiated
2020-08-03
FDA classified
2020-08-20
Posted by FDA
2020-08-26
Terminated
2021-03-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1513-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.